UNCY
Unicycive Therapeutics
$3.76
+$0.15 (+4.16%)Oct 28, 2026
Key metrics
The numbers that frame UNCY today
- Market cap
- $104.74M
- ROIC
- -1,916.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.35
- 52wk High
- $8.74
Growth
Revenue and earnings trend for UNCY
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about UNCY
Is Unicycive Therapeutics a good buy?
No. Unicycive Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Unicycive Therapeutics is selling at a very high price.
What is the market capitalization of UNCY?
Unicycive Therapeutics's market capitalization is $104.74M.
What is the 52-week high for UNCY stock?
The 52-week high for Unicycive Therapeutics is $8.74. The current close of $3.76 is 57% below that high.
What is the 52-week low for UNCY stock?
The 52-week low for Unicycive Therapeutics is $3.35. The current close of $3.76 is 12.2% above that low.
Does UNCY stock pay dividends?
Unicycive Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for UNCY?
Unicycive Therapeutics's Debt / Equity ratio is 0.01.